Testosterone and Keppra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Testosterone (testosterone) and Keppra (levetiracetam). Common drug interactions include colitis among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Testosterone and Keppra. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Testosterone?

Testosterone has active ingredients of testosterone. It is often used in testosterone. eHealthMe is studying from 6,457 Testosterone users. Check the latest studies of Testosterone.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.



On Jul, 08, 2026

23 people who take Testosterone and Keppra together, and have interactions are studied.

Testosterone and Keppra drug interactions.

What are the common drug interactions of Testosterone and Keppra, by gender? *:

female:

  1. Colitis (inflammation of colon)
  2. Colitis ulcerative (inflammation of colon with ulcer)
  3. Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
  4. Drug ineffective
  5. Fatigue (feeling of tiredness)
  6. Hepatitis b
  7. Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  8. Muscle twitching
  9. Post procedural complication
  10. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)

male:

  1. Fall
  2. Back pain
  3. Anaemia (lack of blood)
  4. Arthralgia (joint pain)
  5. Cardiac arrest
  6. Cerebral haemorrhage (bleeding within the brain)
  7. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  8. Craniocerebral injury (injury to cranium and brain)
  9. Disease progression
  10. Disturbance in attention

What are the common drug interactions of Testosterone and Keppra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Back pain
  2. Myalgia (muscle pain)
  3. Aggression
  4. Pallor
  5. Soliloquy
  6. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)

20-29:

  1. Cellulitis (infection under the skin)
  2. Anaemia (lack of blood)
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  5. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Haematemesis (vomiting of blood)
  8. Hepatitis c
  9. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

30-39:

n/a

40-49:

  1. Colitis (inflammation of colon)

50-59:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
  3. Prostate cancer
  4. Pulmonary embolism (blockage of the main artery of the lung)

60+:

  1. Fatigue (feeling of tiredness)
  2. Headache (pain in head)
  3. Encephalopathy (functioning of the brain is affected by some agent or condition)
  4. Eye pruritus (eye itching)
  5. Fall
  6. Head injury
  7. Hypersensitivity
  8. Hypoacusis (loss of hearing)
  9. Loss of consciousness
  10. Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 4 people, 17.39%
  2. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 13.04%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 13.04%
  4. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 8.70%
  5. Depression: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Testosterone and Keppra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Testosterone and Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Testosterone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Testosterone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keppra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on testosterone and levetiracetam (the active ingredients of Testosterone and Keppra, respectively), and Testosterone and Keppra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: